FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079398575> ?p ?o ?g. }

• W2079398575 endingPage "109" @default.
• W2079398575 startingPage "99" @default.
• W2079398575 abstract "ABSTRACT The Fas–Fas ligand interaction is the most important pathway in starting apoptosis. In addition, several recent reports have emerged documenting non‐apoptotic roles for Fas. However, a non‐apoptotic role of Fas in dermal fibroblasts remains unknown. The present study investigated whether Fas stimulation not only promotes apoptosis but also stimulates elements of the inflammatory response such as angiogenesis and macrophage infiltration. Fas stimulation was performed by treating cultured human dermal fibroblasts with an agonistic anti‐Fas monoclonal antibody (mAb). Anti‐Fas mAb‐treated fibroblasts showed a significantly greater increase of caspase‐3 and caspase‐8 activity compared with control fibroblasts. Addition of the anti‐Fas mAb induced DNA fragmentation, as confirmed by the DNA ladder assay. Terminal deoxynucleotidyl transferase‐mediated 2′‐deoxyuridine 5′‐triphosphate nick end labeling (TUNEL) staining showed that treatment with the anti‐Fas mAb induced an increase of apoptotic fibroblasts in a time‐dependent manner. At both mRNA and protein levels, anti‐Fas mAb‐treated fibroblasts showed significantly higher expression of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein (MCP)‐1 compared with control fibroblasts. A pan‐caspase inhibitor (Z‐VAD‐FMK) significantly inhibited VEGF and MCP‐1 expression. After transplantation of fibroblasts into mice with severe combined immunodeficiency, the nodules derived from anti‐Fas mAb‐treated fibroblasts showed more abundant neovascularization, increased macrophage infiltration, and more apoptotic cells in comparison with nodules derived from control fibroblasts. The results of both in vitro and in vivo studies confirmed significantly higher angiogenic activity and macrophage chemotactic activity of anti‐Fas mAb‐treated fibroblasts compared with control fibroblasts." @default.
• W2079398575 created "2016-06-24" @default.
• W2079398575 creator A5018979358 @default.
• W2079398575 creator A5060996671 @default.
• W2079398575 creator A5062755297 @default.
• W2079398575 creator A5081852407 @default.
• W2079398575 date "2007-01-16" @default.
• W2079398575 modified "2023-10-15" @default.
• W2079398575 title "Fas-mediated upregulation of vascular endothelial growth factor and monocyte chemoattractant protein-1 expression in cultured dermal fibroblasts: Role in the inflammatory response" @default.
• W2079398575 cites W1506642042 @default.
• W2079398575 cites W1601246948 @default.
• W2079398575 cites W1854038799 @default.
• W2079398575 cites W1878993697 @default.
• W2079398575 cites W1964420304 @default.
• W2079398575 cites W1965756947 @default.
• W2079398575 cites W1967588384 @default.
• W2079398575 cites W1976333492 @default.
• W2079398575 cites W1977776769 @default.
• W2079398575 cites W1984696190 @default.
• W2079398575 cites W2000292756 @default.
• W2079398575 cites W2005595106 @default.
• W2079398575 cites W2007127627 @default.
• W2079398575 cites W2007539891 @default.
• W2079398575 cites W2009939768 @default.
• W2079398575 cites W2020585843 @default.
• W2079398575 cites W2022826740 @default.
• W2079398575 cites W2030892254 @default.
• W2079398575 cites W2039667869 @default.
• W2079398575 cites W2045834436 @default.
• W2079398575 cites W2054282009 @default.
• W2079398575 cites W2069146050 @default.
• W2079398575 cites W2093366741 @default.
• W2079398575 cites W2106557745 @default.
• W2079398575 cites W2112911107 @default.
• W2079398575 cites W2125616125 @default.
• W2079398575 cites W2144814682 @default.
• W2079398575 cites W2154552023 @default.
• W2079398575 cites W2162035907 @default.
• W2079398575 cites W2238604969 @default.
• W2079398575 doi "https://doi.org/10.1111/j.1346-8138.2006.00226.x" @default.
• W2079398575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17239146" @default.
• W2079398575 hasPublicationYear "2007" @default.
• W2079398575 type Work @default.
• W2079398575 sameAs 2079398575 @default.
• W2079398575 citedByCount "6" @default.
• W2079398575 countsByYear W20793985752013 @default.
• W2079398575 countsByYear W20793985752015 @default.
• W2079398575 crossrefType "journal-article" @default.
• W2079398575 hasAuthorship W2079398575A5018979358 @default.
• W2079398575 hasAuthorship W2079398575A5060996671 @default.
• W2079398575 hasAuthorship W2079398575A5062755297 @default.
• W2079398575 hasAuthorship W2079398575A5081852407 @default.
• W2079398575 hasConcept C153911025 @default.
• W2079398575 hasConcept C167734588 @default.
• W2079398575 hasConcept C185592680 @default.
• W2079398575 hasConcept C190283241 @default.
• W2079398575 hasConcept C196795494 @default.
• W2079398575 hasConcept C203014093 @default.
• W2079398575 hasConcept C2777025900 @default.
• W2079398575 hasConcept C2780394083 @default.
• W2079398575 hasConcept C2781184567 @default.
• W2079398575 hasConcept C31573885 @default.
• W2079398575 hasConcept C502942594 @default.
• W2079398575 hasConcept C55493867 @default.
• W2079398575 hasConcept C66008609 @default.
• W2079398575 hasConcept C86803240 @default.
• W2079398575 hasConcept C95444343 @default.
• W2079398575 hasConceptScore W2079398575C153911025 @default.
• W2079398575 hasConceptScore W2079398575C167734588 @default.
• W2079398575 hasConceptScore W2079398575C185592680 @default.
• W2079398575 hasConceptScore W2079398575C190283241 @default.
• W2079398575 hasConceptScore W2079398575C196795494 @default.
• W2079398575 hasConceptScore W2079398575C203014093 @default.
• W2079398575 hasConceptScore W2079398575C2777025900 @default.
• W2079398575 hasConceptScore W2079398575C2780394083 @default.
• W2079398575 hasConceptScore W2079398575C2781184567 @default.
• W2079398575 hasConceptScore W2079398575C31573885 @default.
• W2079398575 hasConceptScore W2079398575C502942594 @default.
• W2079398575 hasConceptScore W2079398575C55493867 @default.
• W2079398575 hasConceptScore W2079398575C66008609 @default.
• W2079398575 hasConceptScore W2079398575C86803240 @default.
• W2079398575 hasConceptScore W2079398575C95444343 @default.
• W2079398575 hasIssue "2" @default.
• W2079398575 hasLocation W20793985751 @default.
• W2079398575 hasLocation W20793985752 @default.
• W2079398575 hasOpenAccess W2079398575 @default.
• W2079398575 hasPrimaryLocation W20793985751 @default.
• W2079398575 hasRelatedWork W1028463617 @default.
• W2079398575 hasRelatedWork W1951460484 @default.
• W2079398575 hasRelatedWork W2024146942 @default.
• W2079398575 hasRelatedWork W2209341281 @default.
• W2079398575 hasRelatedWork W2361549486 @default.
• W2079398575 hasRelatedWork W2369124635 @default.
• W2079398575 hasRelatedWork W3031363166 @default.
• W2079398575 hasRelatedWork W3031715813 @default.
• W2079398575 hasRelatedWork W31185521 @default.
• W2079398575 hasRelatedWork W4232760164 @default.
• W2079398575 hasVolume "34" @default.

• next